2017
Evaluation and Management of Erectile Dysfunction in the Hypertensive Patient
Patel JP, Lee EH, Mena-Hurtado CI, Walker CN. Evaluation and Management of Erectile Dysfunction in the Hypertensive Patient. Current Cardiology Reports 2017, 19: 89. PMID: 28836189, DOI: 10.1007/s11886-017-0889-z.Peer-Reviewed Original ResearchMeSH KeywordsAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsErectile DysfunctionHumansHypertensionMalePhosphodiesterase 5 InhibitorsConceptsErectile dysfunctionHypertensive patientsSexual functionCertain antihypertensive agentsAngiotensin receptor blockersChallenging patient populationFirst-line treatmentDiagnosis of hypertensionCalcium channel blockersTreatment of hypertensionPDE-5 inhibitorsAntihypertensive agentsReviewThe prevalencePatient populationPharmacological treatmentRisk factorsChannel blockersClinical challengeCardiovascular fitnessHypertensionEnzyme inhibitorsPatientsDysfunctionAdverse effectsSexual activity
2013
The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy.
Meller SM, Stilp E, Walker CN, Mena-Hurtado C. The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy. Journal Of Invasive Cardiology 2013, 25: 313-9. PMID: 23735361.Peer-Reviewed Original ResearchConceptsPeripheral artery diseaseCoronary artery diseaseVasculogenic erectile dysfunctionErectile dysfunctionArtery diseaseEndovascular therapyMetabolic factorsPathophysiology of EDArtery size hypothesisIncident clinical eventsPelvic arterial anatomyLarge prospective studiesCommon risk factorsQuality of lifeDiagnostic imaging modalitiesMacrovascular diseasePercutaneous revascularizationEndothelial dysfunctionDiabetes mellitusPathophysiological linkProspective studyArterial anatomyClinical eventsCurrent therapiesRisk factors